← 709 (USA)

709-1259

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 709 (USA) (Dr. Novak) · consented 2013-01-26
Adverse events
11
Serious AEs
0
Open data queries
0
Luna dropout signal

Adverse events

mild assessed 2026-08-18

Mild BENIGN PROSTATIC HYPERPLASIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-17 (study day 51.0); relationship: NONE; serious criteria: hospitalization

severe assessed 2026-08-18

Severe BENIGN PROSTATIC HYPERPLASIA — outcome: RECOVERED/RESOLVED; onset 2013-03-17 (study day 51.0); relationship: NONE; serious criteria: hospitalization

mild assessed 2026-08-18

Mild BLOOD URINE PRESENT — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-14 (study day 48.0); relationship: NONE

mild assessed 2026-08-18

Mild CYSTOSCOPY — outcome: RECOVERED/RESOLVED; onset 2013-03-17 (study day 51.0); relationship: NONE

mild assessed 2026-08-18

Mild DEHYDRATION — outcome: RECOVERED/RESOLVED; onset 2013-04-13 (study day 78.0); relationship: NONE

mild assessed 2026-08-18

Mild HYPOTENSION — outcome: RECOVERED/RESOLVED; onset 2013-04-13 (study day 78.0); relationship: POSSIBLE; serious criteria: hospitalization

mild assessed 2026-08-18

Mild LOCALISED INFECTION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-02-05 (study day 11.0); relationship: NONE

mild assessed 2026-08-18

Mild LOCALISED INFECTION — outcome: RECOVERED/RESOLVED; onset 2013-02-05 (study day 11.0); relationship: NONE

mild assessed 2026-08-18

Mild ORTHOSTATIC HYPOTENSION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-04-20 (study day 85.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild ORTHOSTATIC HYPOTENSION — outcome: RECOVERED/RESOLVED; onset 2013-04-20 (study day 85.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild PYREXIA — outcome: RECOVERED/RESOLVED; onset 2013-04-13 (study day 78.0); relationship: NONE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.